ABACAVIR SULFATE
- Product NameABACAVIR SULFATE
- CAS136777-48-5
- CBNumberCB5425547
- MFC14H19ClN6O
- MW322.8
- MDL NumberMFCD18427212
- MOL File136777-48-5.mol
Chemical Properties
ABACAVIR SULFATE Chemical Properties,Usage,Production
Uses
Abacavir hydrochloride is a competitive, orally active nucleoside reverse transcriptase inhibitor. Abacavir hydrochloride can inhibits the replication of HIV. Abacavir hydrochloride shows anticancer activity in prostate cancer cell lines. Abacavir hydrochloride can trespass the blood-brain-barrier and suppresses telomerase activity[1][2][3].Definition
ChEBI: Abacavir sulfate is an azaheterocycle sulfate salt that is the sulfate salt of the HIV-1 reverse transcriptase inhibitor abacavir. It is functionally related to an abacavir.in vivo
Abacavir hydrochloride (100 and 200 mg/kg, p.o.; 4 h) dose-dependently promotes thrombus formation[2].
Abacavir hydrochloride (50 mg/kg/d; i.p.; 14 d) with 0.1 mg/kg/d Decitabine (HY-A0004) enhances survival of high-risk medulloblastoma-bearing mice[3].
| Animal Model: | Male mice (9-weeks old, 22-30 g) - wild-type (WT) C57BL/6 or homozygous knockout (P2rx7 KO, B6.129P2-P2rx7tm1Gab/J)[2] |
| Dosage: | Route 1: 2.5, 5, and 7.5 μg/mL, 100 μL Route 2: 100 and 200 mg/kg |
| Administration: | Intrascrotal or oral administration for 4 h |
| Result: | Dose-dependently promoted thrombus formation. |
| Animal Model: | NSGTM mice, patient-derived xenograft (PDX) cells of non-WNT/non-SHH, Group 3 and of SHH/ TP53-mutated medulloblastoma[3] |
| Dosage: | 50 mg/kg/d with 0.1 mg/kg/d Decitabine |
| Administration: | Intraperitoneal injection, daily for 14 days |
| Result: | Inhibited tumor growth and enhanced mouse survival. |
References
[1] Carlini F, et al. The reverse transcription inhibitor abacavir shows anticancer activity in prostate cancer cell lines. PLoS One. 2010 Dec 3;5(12):e14221. DOI:10.1371/journal.pone.0014221[2] Collado-Diaz V, et al. Abacavir Induces Arterial Thrombosis in a Murine Model. J Infect Dis. 2018 Jun 20;218(2):228-233. DOI:10.1093/infdis/jiy001
[3] Gringmuth M, et al. Enhanced Survival of High-Risk Medulloblastoma-Bearing Mice after Multimodal Treatment with Radiotherapy, Decitabine, and Abacavir. Int J Mol Sci. 2022 Mar 30;23(7):3815. DOI:10.3390/ijms23073815
[4] McComsey GA, et al. Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zidovudine. AIDS. 2005 Jan 3;19(1):15-23. DOI:10.1097/00002030-200501030-00002
ABACAVIR SULFATE Supplier
Global(32)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| +919099003427 | source@jigschmical.com | Gujarat,India | 234 | 58 | |
| +91-8019896181 | info@lupin.com | Maharashtra,India | 91 | 58 | |
| +91-40-49002900 | krishnaraoy@drreddys.com | Beijing,India | 197 | 58 | |
| 91-40-49002900 | rashish@drreddys.com | Hyderabad,India | 59 | 58 | |
| +91-172-5066494 | mktg@pharmaffiliates.com | Haryana,India | 6665 | 58 | |
| +86-29-81148696 +86-15129568250 | 1022@dideu.com | 29083 | 58 | ||
| +86-571-85134551 +86-18958018566 | info@afinechem.com | 15118 | 58 | ||
| +86-0551-65418684 +86-18949823763 | sales@tnjchem.com | 25332 | 58 | ||
| +86-18168183658 | sales1@artkmedchem.com | 39006 | 58 | ||
| +8618950047208 | ellena@amitychem.com | 43392 | 58 |